Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX Receives Frost & Sullivan Award

Published: Thursday, September 12, 2013
Last Updated: Thursday, September 12, 2013
Bookmark and Share
AB SCIEX has been awarded the 2013 Global Market Share Leadership Award for Mass Spectrometry from Frost & Sullivan.

AB SCIEX is ranked #1 in the mass spectrometry technology industry once again, according to an independent market research firm that tracks revenues and unit sales globally in the highly competitive sector of scientific instrumentation.  

The following are excerpts from the Frost & Sullivan report that accompanied the award, which was formally presented to AB SCIEX representatives last night at a gala event in San Jose, California:

• Staying Ahead of the Competition:  “AB Sciex has established an aggressive and successful R&D strategy to remain a step ahead of its competitors.”

• Innovation with the Highest Value: “The firm continues to focus on innovation and new product development to advance the field of mass spectrometry and make the technology more accessible on both ends of the budget spectrums.”

• Best-in-Class Instrumentation:  “AB Sciex’s highest performing 6500 Series is now widely considered the industry’s top-selling high-end triple quadrupole, setting benchmarks in sensitivity and performance.” 

• Leader Who Listens:  “By listening to and understanding the rapidly changing needs of its customers, AB Sciex has been able to build a product line that achieves unmatched sensitivity and performance, while making the technology accessible to the masses.”

• Largest Installed Base Worldwide:  “By developing a trusted and well-established line of high-quality instruments and software, combined with a feverish pace of technology improvement, AB Sciex will retain its status as the most widely-used portfolio of mass spectrometers.”

• Navigating to Meet Market Demand: “During a slow economy where capital equipment budgets have been slashed, the ability to bring cutting-edge high-end technologies to market, and find a willing marketplace, is a testament to the industry’s demand for AB Sciex systems.”  

• Continued Leadership: “With a trusted brand name, updated cutting-edge products, and a sole focus on being the premier provider of mass spectrometry tools, AB Sciex is expected to maintain its firm grip of the market share lead.”  

“We are extremely pleased by the independent confirmation of our leadership in the mass spectrometry industry,” said Rainer Blair, President of AB SCIEX.  “When scientists, lab managers and technologists consider mass spectrometry to help them achieve their goals, AB SCIEX should be the first place they look for all the reasons that the Frost & Sullivan market report details.  We’ve been a leader in mass spectrometry for decades and we intend to stay the leader through continued innovation and the industry’s best service and support.”   

The full report from Frost & Sullivan can be downloaded below.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

AB SCIEX Wins New Product Innovation Award in Asia Pacific
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.
Thursday, October 30, 2014
AB SCIEX Announces In Vitro Diagnostic Devices CE Marked for Europe
AB SCIEX launches the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.
Tuesday, May 21, 2013
AB SCIEX Achieves ISO 13485 Certification for Manufacturing of LC/MS Systems
This ISO certification is often considered a first step toward complying with European regulatory requirements for a device to be cleared for use in the clinic.
Monday, February 27, 2012
Scientific News
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Loss Of Y Chromosome Increases Risk Of Alzheimer’s
Men with blood cells that do not carry the Y chromosome are at greater risk of being diagnosed with Alzheimer’s disease. This is in addition to an increased risk of death from other causes, including many cancers. These new findings by researchers at Uppsala University could lead to a simple test to identify those at risk of developing Alzheimer’s disease.
Making Virus Sensors Cheap and Simple
Researchers at The University of Texas at Austin demonstrated the ability to detect single viruses in a solution containing murine cytomegalovirus (MCMV).
Heart Defect Prediction Technology Could Lead to Earlier, More Informed Treatment
Experimental method uses genetics-guided biomechanics, patient-specific stem cells.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Big Data Can Save Lives
The sharing of genetic information from millions of cancer patients around the world could be key to revolutionising cancer prevention and care, according to a leading cancer expert from Queen's University Belfast.
Fast, Simple Test for Colitis
A minimally invasive screening for ulcerative colitis using emerging infrared technology could be a rapid and cost-effective method for detecting disease that eliminates the need for biopsies and intrusive testing of the human body.
Scans Reveal Babies of Mothers with Gestational Diabetes Have More Body Fat
Researchers at Imperial College London have found that the babies born to mothers with gestational diabetes have more body fat at two months of age compared to babies born to healthy mothers.
New Device Could Improve Cancer Detection
UBC researchers develop a microfluidic device to capture circulating tumor cells.
Plasma Biomarkers for Breast Cancer Diagnosis
Plasma lipidomics profiling identified lipid biomarkers in distinguishing early-stage breast cancer from benign lesions.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!